scholarly journals Are Emergency Providers’ Knowledge and Perceptions of HIV and Hepatitis C Guidelines Influencing Their Practice?  A Pilot Study in Appalachia

Author(s):  
Hannah R. Maier ◽  
Levi A. Nolan ◽  
Melinda J. Sharon ◽  
Carmen N. Burrell

Abstract Background: There is increasing concern of unidentified infectious diseases, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV), due to the recent opioid epidemic. The purpose of this study was to assess emergency physicians’, advanced practice providers’ (APPs), and registered nurses’ (RNs) knowledge and perceptions of the current Center for Disease Control and Prevention (CDC) HIV and HCV screening guidelines and how it may affect their routine practice habits. Methods: A 25-item electronic survey was distributed to emergency physicians, APPs, and RNs from two emergency departments in West Virginia. Data were analyzed descriptively across all variables. Results: In October 2018, 47 providers completed the survey. Of those, 29 (62%) selected the correct HCV screening protocols, and 67% (31) reported they currently suggest HCV screenings to their patients. Although only six (13%) providers selected the correct HIV protocols, a larger proportion of 73% (34) suggest HIV screenings during their patient encounters. Reasons listed for not conducting these screenings while on shift included “not an emergency” and “not my role as an EM doc.” However, reasons that would make providers more likely to screen included “free screening for patients” and “results available faster.” Conclusions: This pilot study was the first to assess knowledge and perceptions of HCV and HIV screenings among a variety of Appalachian emergency providers. Our results suggest that all categories of providers surveyed lack appropriate knowledge of the current CDC screening guidelines and have varying attitudes toward screening behaviors, which could affect consistent practice to identify new infection.

2015 ◽  
Vol 110 ◽  
pp. S877-S878
Author(s):  
Zobair M. Younossi ◽  
Louis L. LaLuna ◽  
John J. Santoro ◽  
Flavia Mendes ◽  
Victor Araya ◽  
...  

Author(s):  
Antoine Chaillon ◽  
Adriane Wynn ◽  
Tatyana Kushner ◽  
Nancy Reau ◽  
Natasha K Martin

Abstract To inform proposed changes in U.S. HCV screening guidelines, we assessed the cost-effectiveness of HCV antenatal rescreening for women without evidence of HCV during a prior pregnancy, using a previously published model. Universal HCV rescreening among pregnant women was cost-effective (ICER $6,000/QALY) and should be recommended nationally.


2018 ◽  
Vol 7 (2) ◽  
pp. e000108 ◽  
Author(s):  
Jane Trinh ◽  
Nicholas Turner

BackgroundHepatitis C (HCV) is a viral liver disease that can result in cirrhosis, hepatocellular carcinoma, liver transplantation or death. The Centers for Disease Control (CDC) estimates that 2.7–3.9 million Americans are living with HCV, yet the majority are unaware. Starting in 2013, both CDC and US Preventative Services Task Force guidelines agreed in recommending HCV screening for all those born between 1945 and 1965 yet many clinics have been slow to adopt screening.ObjectiveWe designed a quality improvement project seeking to improve HCV screening rates among patients seen for new or annual visits to ≥90% over a 3-year period in an academic primary care clinic.MethodsScreening rates were assessed through repeated review of charts (50 per cycle or 300 charts total, roughly 35% of eligible visits) as a series of interventions were executed. Sustainability was assessed by repeating an additional 50-chart analysis 1 year after completion of the study interventions. At the conclusion of the study, a post hoc analysis of socioeconomic factors was undertaken to determine whether gender, income or ethnicity might affect screening rates.ResultsOver 6 cycles of interventions, screening rates improved from 24% to ≥90%. Screening rates remained at 88% 1 year after completion of the interventions. The most effective interventions used reminders built into our electronic medical record and informed providers of their personal HCV screening rates relative to the clinic as a whole. Our post hoc analysis found that lower socioeconomic standing and white race were associated with reduced likelihood of screening.ConclusionsProvider adoption of new HCV screening guidelines can be markedly and sustainably increased with electronic medical record prompts as well as directed feedback informing providers of their personal screening rates compared with colleagues.


2017 ◽  
Vol 64 (12) ◽  
pp. 1711-1720 ◽  
Author(s):  
Debika Bhattacharya ◽  
Pamela S. Belperio ◽  
Troy A. Shahoumian ◽  
Timothy P. Loomis ◽  
Matthew B. Goetz ◽  
...  

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Monica L. Kasting ◽  
Julie Rathwell ◽  
Kaitlyn M. Gabhart ◽  
Jennifer Garcia ◽  
Richard G. Roetzheim ◽  
...  

Abstract Background Liver cancer rates are rising and hepatitis C virus (HCV) is the primary cause. The CDC recommends a one-time HCV screening for all persons born 1945–1965 (baby boomers). However, 14% of baby boomers have been screened. Few studies have examined primary care providers’ (PCP) perspectives on barriers to HCV screening. This study examines current HCV screening practices, knowledge, barriers, and facilitators to HCV screening recommendation for baby boomers among PCPs. Methods We conducted a mixed methods pilot study of PCPs. Quantitative: We surveyed PCPs from 3 large academic health systems assessing screening practices, knowledge (range:0–9), self-efficacy to identify and treat HCV (range:0–32), and barriers (range:0–10). Qualitative: We conducted interviews assessing patient, provider, and clinic-level barriers to HCV screening for baby boomers in primary care. Interviews were audio recorded, transcribed, and analyzed with content analysis. Results The study sample consisted of 31 PCPs (22 survey participants and nine interview participants). All PCPs were aware of the birth cohort screening recommendation and survey participants reported high HCV testing recommendation, but qualitative interviews indicated other priorities may supersede recommending HCV testing. Provider knowledge of viral transmission was high, but lower for infection prevalence. While survey participants reported very few barriers to HCV screening in primary care, interview participants provided a more nuanced description of barriers such as lack of time. Conclusions There is a need for provider education on both HCV treatment as well as how to effectively recommend HCV screening for their patients. As HCV screening guidelines continue to expand to a larger segment of the primary care population, it is important to understand ways to improve HCV screening in primary care.


2009 ◽  
Vol 30 (12) ◽  
pp. 1227-1229 ◽  
Author(s):  
Maria Gańczak ◽  
Zbigniew Szych

We describe the prevalence of anti-human immunodeficiency virus (anti-HIV) among a sample of 1,652 surgical and gynecologic patients in Polish hospitals, contrasting it with the prevalence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (anti-HCV) to assess the rationale for preoperative testing. No anti-HIV-positive samples were found; the prevalence of anti-HCV was 0.9%, slightly higher than the prevalence of HBsAg of 0.6%. Universal preoperative screening of hospital patients for HIV is currently not warranted according to the Centers for Disease Control and Prevention guidelines. However, the seroprevalence of HIV should be reassessed periodically.


2001 ◽  
Vol 36 (3) ◽  
pp. 225-234
Author(s):  
Ramazan Idilman ◽  
Alessandra Colantoni ◽  
Nicola De Maria ◽  
James M. Harig ◽  
David H. van Thiel

Sign in / Sign up

Export Citation Format

Share Document